Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 21, 2015; 21(3): 913-918
Published online Jan 21, 2015. doi: 10.3748/wjg.v21.i3.913
Published online Jan 21, 2015. doi: 10.3748/wjg.v21.i3.913
Table 3 Prevalence of steatosis and hepatic fibrosis according to type of hepatic neoplasm
Histologic type (n) | Liver steatosis | Liver fibrosis | ||||
n (%) | P value | OR (95%CI) | n (%) | P value | OR (95%CI) | |
LMCC (40) | 22 (55.0) | < 0.0011 | 3.99 (1.78-8.94) | 15 (37.5) | 0.053 | 0.47 (0.21-1.02) |
NCLM (48) | 11 (22.9) | 0.034 | 0.42 (0.18-0.95) | 24 (50.0) | 1.000 | 1.00 (0.48-2.08) |
HCC (16) | 4 (25.0) | 0.406 | 0.60 (0.18-2.01) | 12 (75.0) | 0.0321 | 3.50 (1.06-11.57) |
IHCC (11) | 3 (27.3) | 0.613 | 0.70 (0.18-2.80) | 7 (63.6) | 0.343 | 1.85 (0.51-6.68) |
- Citation: Schulz PO, Ferreira FG, Nascimento MFA, Vieira A, Ribeiro MA, David AI, Szutan LA. Association of nonalcoholic fatty liver disease and liver cancer. World J Gastroenterol 2015; 21(3): 913-918
- URL: https://www.wjgnet.com/1007-9327/full/v21/i3/913.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i3.913